900+ attendees in 2019

200+ Speakers

2019 Exhibition Sold Out

30+ Patients

89% Top 50 pharma confirmed in 2019

As the complexity of US health continues to grow, RWE is pharma’s silver bullet. Technology has unlocked the ability to analyze unprecedented quantities of data, creating analytics that can crunch millions of health records to unveil never-seen-before insights into an individual patient. There is no doubt that RWD can completely uproot traditional healthcare to provide patient value – but the only way to achieve this is collaboration. We must eradicate data silos, set standards with stakeholders and ensure the empowered patient sits at the center. This requires a new mindset, but do it right, and your company will enter a new era of data enlightenment.

The meeting was useful in understanding how different companies approached RWE and value propositions. The presentations were very practical, and I left with a lot of new insights. Director, RWE, Vertex Pharmaceuticals
Get the brochure

Real-World Evidence Speakers Include:

Sonal BhatiaVice President, North America Medical Lead, Rare Diseases

Sonal Bhatia

Shurjeel ChoudhriSenior Vice President and Head, Medical and Scientific Affairs

Shurjeel Choudhri

Christopher BooneVP, Global RWE CoE, Patient & Health Impact

Christopher Boone

The Key Real-World Evidence Themes 

Break Siloes Power a new era of innovation through RWE-driven science

Quality Control Set standards for Real-World Evidence to win stakeholder trust

Early Approval Unlock Phase II launch to save costs and lives through RWE

Discover Patient Needs Use RWD to connect to patient experience and align your product for maximum impact

New for 2019
Everything you need to know about eyeforpharma Philadelphia in 60 seconds

Josh Bramwell

Josh Bramwell
Head of Product

+44 (0) 207 375 7203

Izzy Gladstone

Izzy Gladstone
Head of Marketing

+1 347 458 1621

Michael Mayhew

Michael Mayhew
Global Project Director

+44 (0) 207 375 4335